Balancing Modern Medical Benefits And Risks

摘要: The changing landscape of medical benefits and risks creates new challenges for all stakeholders in health care. We offer examples different interventions to help illustrate the complexity diversity considerations that define trade-offs between each patient. As more information becomes available at stages a product’s life cycle, Food Drug Administration (FDA) needs play central role as an authoritative voice communicating drugs’ must have resources perform functions necessary keep pace with this accelerating rate change.